Discrepancies between anti-Intereukin5 ( anti-IL5) starters from SHARP central registry and eligible patients in clinical trials

被引：0
|
作者：
Principe, S. [1 ]
Richards, L. B. [1 ,2 ]
Hashimoto, S. [1 ,2 ]
Kroes, J. A. [3 ]
Van Bragt, J. J. [1 ,2 ]
Vijverberg, S. J. [1 ,2 ]
Sont, J. K. [4 ]
Scichilone, N. [2 ]
Bieksiene, K. [5 ]
Brinke, A. T. [6 ]
Csoma, Z. [7 ]
Dahlen, B. [8 ]
Gemicioglu, B. [9 ]
Grisle, I [10 ]
Kuna, P. [11 ]
Lazic, Z. [12 ]
Mihaltan, F. [13 ]
Popovic-Grle, S. [14 ]
Skgrat, S. [15 ]
Van der Zee, A. Maitland [1 ,2 ]
机构：
[1] Univ Amsterdam, Dept Resp Med, Med Ctr, Amsterdam, Netherlands
[2] Univ Palermo, Dept Pulmonol, AOUP Policlin Paolo Giaccone, Palermo, Italy
[3] Med Ctr Leeuwarden, Dept Clin Pharm & Pharmacol, Leeuwarden, Netherlands
[4] Leiden Univ, Dept Biomed Data Sci, Sect Med Decis Making, Med Ctr, Leiden, Netherlands
[5] Lithuanian Univ Hlth Sci, Dept Pulmonol, Kaunas, Lithuania
[6] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[7] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[8] Karolinska Inst, Stockholm, Sweden
[9] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Pulm Dis, Istanbul, Turkey
[10] Riga East Univ Hosp, Riga, Latvia
[11] Med Univ Lodz, Lodz, Poland
[12] Univ Clin Ctr Kragujevac, Kragujevac, Serbia
[13] Natl Inst Pneumol, Bucharest, Romania
[14] Univ Hosp Ctr Zagreb, KBCZ Clin Ctr Pulm Dis Jordanovac, Zagreb, Croatia
[15] Univ Ljubljana, Univ Med Ctr Ljubljana, Med Fac, Pulm Dept, Ljubljana, Slovenia
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2197
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2197
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Changing between anti-IL5 and anti-IL5 receptor treatments. A real-life study
    Bjerrum, Anne Sofie
    Skjold, Tina
    Andersen, Helle
    Pedersen, Lene
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Worldwide Characterization of Severe Asthma Patients Eligible for Both Anti-IL5 and Anti-IgE: Data from the International Severe Asthma Registry (ISAR)
    Sadatsafavi, M.
    Murray, R.
    Ali, N.
    Trung, T.
    Price, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Identifying Asthma Patients Eligible for Anti-IL5 Treatment Using Electronic Health Records
    Yang, F.
    Lee, N.
    Thomson, N. C.
    Shepherd, M.
    Chaudhuri, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [4] Change of Antibody Therapy in severe Eosinophilic Bronchial Asthma from Anti-IL5 to Anti-IL5 Receptor Antibodies
    Drick, N.
    Milger, K.
    Korn, S.
    Buhl, R.
    Schuhmann, M.
    Herth, F. J. F.
    Kendziora, B.
    Bergmann, K. C.
    Taube, C.
    Welte, T.
    Suhling, H.
    PNEUMOLOGIE, 2020, 74 : S9 - S10
  • [5] Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
    Pfeffer, Paul E.
    Ali, Nasloon
    Murray, Ruth
    Ulrik., Charlotte
    Tran, Trung N.
    Maspero, Jorge
    Peters, Matthew
    Christoff, George C.
    Sadatsafavi, Mohsen
    Torres-Duque, Carlos A.
    Altraja, Alan
    Lehtimaki, Lauri
    Papadopoulos, Nikolaos G.
    Salvi, Sundeep
    Costello, Richard W.
    Cushen, Breda
    Heffler, Enrico
    Iwanaga, Takashi
    Al-Ahmad, Mona
    Larenas-Linnemann, Desiree
    Kuna, Piotr
    Fonseca, Joao A.
    Al-Lehebi, Riyad
    Rhee, Chin Kook
    Perez-de-Llano, Luis
    Perng Steve, Diahn-Warng
    Mahboub, Bassam
    Wang, Eileen
    Goh, Celine
    Lyu, Juntao
    Newell, Anthony
    Alacqua, Marianna
    Belevskiy, Andrey S.
    Bhutani, Mohit
    Bjermer, Leif
    Bjornsdottir, Unnur
    Bourdin, Arnaud
    von Boulow, Anna
    Busby, John
    Canonica, Giorgio Walter
    Cosio, Borja G.
    Dorscheid, Delbert R.
    Munoz-Esquerre, Mariana
    FitzGerald, J. Mark
    Gil, Esther Garcia
    Gibson, Peter G.
    Heaney, Liam G.
    Hew, Mark
    Hilberg, Ole
    Hoyte, Flavia
    ALLERGY, 2023, 78 (07) : 1934 - 1948
  • [6] Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Cetin, Gulden Pacaci
    Arslan, Bahar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1935 - 1936
  • [7] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [8] Late Breaking Abstract- Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
    Ali, Nasloon
    Lyu, Juntao
    Newell, Anthony
    Sadatsafavi, Mohsen
    Tran, Trung N.
    Price, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] An Observation of Infection Risks in Severe Asthma Patients on Anti-IL5 Therapy
    Basirat, A.
    Maxwell, J.
    Joseph, J.
    Bradley, A.
    Moloney, E.
    Subramaniam, A.
    Lane, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 1) : S55 - S55
  • [10] Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
    Carpagnano, Giovanna Elisiana
    Portacci, Andrea
    Nolasco, Santi
    Detoraki, Aikaterini
    Vatrella, Alessandro
    Calabrese, Cecilia
    Pelaia, Corrado
    Montagnolo, Francesca
    Scioscia, Giulia
    Valenti, Giuseppe
    D'Amato, Maria
    Caiaffa, Maria Filomena
    Triggiani, Massimo
    Scichilone, Nicola
    Crimi, Claudia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345